WHO’s New Obesity Medication Guidelines
The World Health Organization (WHO) has recently issued groundbreaking guidelines on the use of glucagon-like peptide-1 (GLP-1) based therapies for the treatment of obesity, marking a significant shift in global health policy. These guidelines emphasize the recognition of obesity as a chronic, relapsing disease, affecting over a billion people worldwide, and the importance of long-term, […]
Read more →